Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Feb 29;19(2):e0294305. doi: 10.1371/journal.pone.0294305

Evaluation of the environmental polio surveillance system—Northern Region, Ghana, 2021

Benjamin Baguune 1,2, Eunice Baiden Laryea 2,#, Joseph Asamoah Frimpong 2,*,#, Samuel Dapaa 2,#, Kwame Kodom Achempem 3,, Ernest Kenu 2, Dennis Odai Laryea 3,
Editor: Enoch Aninagyei4
PMCID: PMC10903872  PMID: 38422061

Abstract

Background

Acute Flaccid Paralysis (AFP) surveillance is the gold standard in the polio eradication initiative. The environmental component of polio surveillance can detect circulating Polioviruses from sewage without relying on clinical presentation. The effectiveness of the Environmental Surveillance (ES) is crucial to global polio eradication. We assessed the usefulness and attributes of the ES system in the Northern region and determined if the system is meeting its objectives.

Methods

We conducted a descriptive cross-sectional evaluation in the Northern region from 2019 to 2020 using the updated US Centers for Disease Control and Prevention guideline. We interviewed stakeholders, reviewed records, and observed surveillance activities from 29th March to 7th May, 2021. Quantitative data were analyzed manually as frequencies and proportions whiles thematic analysis was used for the qualitative data.

Results

One of 48 (2.1%) samples collected tested positive for circulating vaccine-derived Poliovirus (cVDPV). The cVDPV detection triggered enhanced AFP surveillance that resulted in the identification of a case of AFP. Three rounds of polio vaccination campaigns were organized. All surveillance officers interviewed were willing to continue providing their services for the ES. Reporting form has few variables and is easy to complete. The completeness of forms was 97.9% (47/48). Samples collected were dispatched on the same day to the testing laboratory. The system’s data was managed manually.

Conclusion

The system was useful in detecting polio outbreaks. Data quality was good, the system was simple, flexible, acceptable, representative, and fairly stable. Sensitivity was high but predictive value positive was low. Timeliness in reporting was good but feedback from the national level could not be assessed. There is a need to improve on the feedback system and ensure that, the surveillance data is managed electronically.

Introduction

Poliomyelitis is an infectious disease caused by the Poliovirus which affects mostly children below the age of 15 years [1]. The characteristics of this infectious disease range in severity from a non-specific illness to severe flaccid paralysis sometimes with permanent disability [2]. Irrespective of the presence or absence of clear clinical symptoms, Poliovirus replication is considered to continue in the para-intestinal submucosal lymphatic tissue from several weeks to a few months [3]. As a result of the Global Polio Eradication Initiative (GPEI), polio cases have decreased by over 99% since 1988 [4]. The number of cases of paralytic poliomyelitis is low, there have been no polio cases due to wild type 2 or type 3 Poliovirus since October 1999 and November 2012 respectively. This was accomplished by the wide use of live attenuated oral polio vaccine (OPV) [4]. This leaves wild poliovirus type 1 and vaccine-derived polioviruses (VDPV) as the main agents responsible for polio events, with VDPV currently outnumbering the wild types [4]. A vaccine-derived Poliovirus is a strain related to the weakened live Poliovirus contained in oral polio vaccine, if allowed to circulate in under or unimmunized populations for a long time, or replicate in immunodeficient individuals, the weakened virus can revert to a form that causes illness and paralysis.

In sub-Saharan Africa, the vast majority of global polio cases were found in Nigeria [5]. Nigeria however reported its last case of Wild Poliovirus in 2016 [5]. Africa has remained polio-free since 2016 [5]. In Ghana, a total of 54 wild polioviruses (all type 1) were recorded from 1996, when Ghana launched its polio eradication initiative, to 2008, when the last wild poliovirus was detected in the Northern region [6]. Ghana was later certified polio free in 2015 after over five years of having no reported case of poliovirus [6].

A new challenge to the polio eradication process has emerged as a public health emergency due to circulating vaccine-derived poliovirus type 2 (cVDPV2) [6]. By August 2020, 323 cases of cVDPV2 and 84 cVDPV2 positive environmental samples were reported from Africa [7]. In Ghana, the first cVDPV2 positive environmental sample was recorded in June 2019 whereas the first human case of cVDPV2 was recorded in August same year [7]. At the end of 2020, 30 cases of cVDPV2 were recorded in Ghana [7].

Continuous collection and analysis of epidemiological data to monitor the trend of Polio cases is therefore crucial in the context of the Global Polio Eradication Initiative (GPEI). The AFP surveillance system is the gold standard in monitoring Polio cases. An AFP case is defined as any child under 15 years with sudden onset of paralysis or weakness in any of the limbs or any person at any age in whom a clinician suspects Poliomyelitis [6]. AFP is a complex clinical syndrome with several different etiologies including paralytic polio caused by wild Poliovirus or circulating vaccine-derived Poliovirus, Guillian-Barre syndrome (GBS), transverse myelitis, traumatic neuritis, meningitis, encephalitis, and brain tumours [8]. AFP surveillance includes the detection and investigation of all AFP cases. It has been adopted globally as an essential strategy for monitoring the progress of the polio eradication initiative [9]. AFP surveillance is essential in every nation to timely detect paralytic poliomyelitis due to wild Poliovirus, to respond effectively to interrupt Poliovirus transmission, and to certify the absence of wild Poliovirus circulation in countries with a polio-free status [9].

The AFP Surveillance does not include the detection of the Poliovirus in the environment. Poliovirus in the mucosal lining is excreted into the faeces and shed into the environment. Hence, it is possible to have a Poliovirus in circulation in any environment contaminated with human faeces. The environment, therefore, offers an anonymous and non-invasive approach to monitor the indication of possible Poliovirus circulation in populations at risk to complement the Acute Flaccid Paralysis (AFP) surveillance system [10]. As the GPEI moves towards achieving the goal of polio eradication, many nations have included Environmental Surveillance (ES) for Poliovirus as a component of the Polio surveillance system. A person infected with the Poliovirus irrespective of whether symptomatic or not shed large amounts of Polioviruses in the faeces for several weeks after infection [11]. The ES monitors and detects the possible transmission of Poliovirus in human populations by examining environmental specimens supposedly contaminated by human faeces [11]. Several countries in Africa such as Nigeria, Kenya, South Africa, Senegal, Cameroon, Madagascar, and Ghana perform ES to detect the circulation of Polioviruses to supplement the effort of the AFP surveillance system [12, 13].

In Ghana, ES for polio is implemented in Greater Accra, Eastern, Volta, Ashanti, Northern, Bono and Bono East. The inclusion of Northern region is important because of the historic wild Poliovirus circulation. ES for polio in the Northern region started in January 2019. It involves the collection of grab sewage/wastewater samples for designated drains in the region. The samples are transported to the Noguchi Memorial Institute for Medical Research (NMIMR) for analysis. Feedback from NMIMR is sent to the reporting unit and depending on the outcome of testing, the necessary public health actions are implemented. ES for polio is a crucial component of the global polio eradication efforts. However, this component of the polio surveillance system in the Northern region of Ghana has never been evaluated. We assessed the usefulness and attributes of the ES system in the Northern region.

Materials and methods

Design and setting

The evaluation was a descriptive cross-sectional design. The updated US Centers for Disease Control and Prevention (CDC) Guideline for Evaluation of Surveillance Systems [14] was adopted. A mixed method approach for data collection was used to collect primary and secondary data for analysis. The evaluation was carried out from 29th March to 7th May, 2021 in the Northern region of Ghana.

The Northern region is one of the sixteen regions of Ghana. It is located in the north of the country and is the second largest of the sixteen regions, covering an area of about 26.4 thousand square kilometres. The Northern Region is divided into 16 districts (Metropolitan assembly, Municipal assemblies and District assemblies). The region’s capital is Tamale. The estimated population from the 2021 population and housing census is 2,310,939. The Region has 32 hospitals, 2 policlinics, 103 clinics and health centres and 171 Community-Based Health Planning and Services compounds. Four criteria were used by a technical assessment team to select the sewer lines and sampling sites in relation to the region: (1) whether the region is classified as high risk for Poliovirus transmission, based on existing data; (2) the presence of sewer lines that receive waste from a considerable proportion of the population in the catchment area, with a minimum amount of waste coming from other areas; (3) the absence of industrial waste in the proposed site; and (4) poor AFP performance indicators. Based on these, the Technical Assessment Team recommended two sites; Nyanshegu in the Sagnarigu Municipal with its drainage settlements as Nyanshegu I, II & III, Sakasaka, Tishigu. Kalpohin, Kunkundanfong, Kanbon Naayili, Ward K, Kanvilli, Tuunayilli, and Kpawumo with a total coverage population of 70,310 and Koblimahgu in the Tamale Metropolis with its drainage settlements as Old and New Koblimahgu, Old and New Jakarayih, Kpambeigu, Kukuo. Bomagu, Zozugu and Atta Esibi with a total coverage population of 32,343. The map of Northern region showing the location of the two ES sites and the location of the cVDPV2 AFP case are shown in Fig 1.

Fig 1. Map of Northern Region showing the location of the two ES sites and the location of the cVDPV2 AFP.

Fig 1

Study participants

In addition to the observations and records reviewed, six Disease Control Officers were interviewed at the Districts and Regional level. In addition, the national environmental surveillance system’s Focal Person and the Officer in-charge of the laboratory investigations at the NMIMR were also contacted through Emails and Telephone calls for certain information that could not be accessed from the Region.

Data collection tool and method

A semi-structured questionnaire was used for data collection. Primary data was collected through face-to-face interviews with key stakeholders. The selection of key stakeholders was done through purposive sampling targeting key officials who are involved in sample collection and transportation, documentation, data management, and use of the surveillance information. A retrospective records review from January 2019 to December 2020 was conducted to extract secondary data from the filled sewage/wastewater sample collection forms. Lastly, an observation of sewage/wastewater sample collection procedure as well as ES-related reports and guidelines were done to gather additional data. The attributes of the ES system for polio were assessed as follows:

Simplicity

Interviews were used to assess this attribute by reviewing the flow of information and lines of response. This includes the type and number of data collection sites, amount and type of information necessary to carry out sample analysis, methods of data transmission, number of organizations involved in receiving sample reports, type of data analysis, and methods of distributing sample information to the users.

Flexibility

This attribute was assessed through reviewing records and interviews, and examining the system’s ability to adapt to changes in new information needs or conditions of operation.

Data quality

Data quality was assessed by reviewing the completeness and clarity of the completed forms for ES samples collected.

Acceptability

Through interviews and records review, this attribute was assessed by examining the willingness of individuals and organizations to participate in the surveillance system. It included the participation rate, the completeness of report forms and timeliness of reporting.

Representativeness

Through interviews and records review, the representativeness of the system was assessed by looking at the drainage coverage, distribution of data collection sites, and data collection pattern.

Timeliness

Timeliness was assessed through interviews and records review. It was done by comparing the time interval between samples collected, the time sample is collected, when it is dispatched to the reference laboratory and the time it takes before final laboratory results are ready.

Stability

Interviews were used to assess this attribute by reviewing the type of personnel involved, the ability to collect samples every month, the ability to collect, manage and provide data at a lower cost, back up when the computer system breaks down, and the number of unplanned power outages that affect the computer operating system.

Sensitivity

Sensitivity was assessed using the number of samples tested positive for viruses (cVDPV2, NPENT, Sabin and NPENT+Sabin) out of the total number of samples collected within the review period.

Predictive value positive

Predictive value positive was assessed using the number of samples tested positive for cVDPV2 out of the total viruses (cVDPV2, NPENT, Sabin and NPENT+Sabin) detected within the review period.

Usefulness of the system

Usefulness was assessed through interviews and reviews of outbreak reports.

Operation of ES in the Northern Region

The operation of the ES is integrated into the existing Ghana Health Service (GHS) disease surveillance system. With regard to reporting, the same system that is being used to transport AFP stool samples and the accompanying documentation is also been used for this ES. Also, the same existing office space and AFP surveillance officers are involved in the ES. Finally, the same notification procedure and the public health actions that take place when an AFP stool tests positive, are also applied when an environmental sample also test positive. Fig 2 depicts the information flow chart of the ES in the Northern Region of Ghana.

Fig 2. ES information flow chart.

Fig 2

The flow chart highlights the components and organizations of the system and how data and information is being shared between stakeholders of the system. The samples are collected from two sources; Nyanshegu in Sagnarigu Municipal and Koblimahgu in Tamale Metropolis. Grab sewage/waste water samples are collected every month from each site by trained collectors. The District Disease Control Officers in these Districts are the supervisors for the data collection exercise. One sample collection form is filled out for each sample collected. Copies of the filled forms and the samples are transported through the region to the NMIMR. The Regional Surveillance Officer also keeps a file of copies of the filled forms as well as scanned copies as backup. After laboratory investigations are done at the NMIMR, feedback is sent to the National Disease Surveillance Department, National office of the World Health Organization, Regional Health Administration and the District Health Administration.

One liter of sewage/wastewater was collected from each site every month between 6:00am and 10:00am. The early morning sample collection was done because that is the estimated peak period for the sewage/wastewater generation. The samples together with the necessary documentation is transported through the reverse cold chain system to the NMIMR. When the filled forms are sent to the region, the officer in charge inspects the forms for completeness. Data is not entered into any electronic system. The filled forms are scanned and stored as backup copies and the hard copies are kept in a file. The system’s information is shared through telephone calls, Emails, and WhatsApp messages. The system is funded by the World Health Organization.

Data analysis and presentation

Data collected at each level was reconciled with all available documents related to the ES in the study area. Quantitative data were analysed manually using summary descriptive statistics such as proportions, frequencies, and means. The ES performance indicators were analysed as follows:

Completeness of sample collection

This was determined by the percentage of samples collected out of the samples scheduled to be collected.

Timeliness of sample collection

This was determined in two ways: (1) the percentage of samples collected on the week assigned out of samples collected; and (2) the percentage of samples collected at the recommended time of day out of samples collected.

Condition of ES sample

This was determined by the percentage of samples that arrive in the laboratory in good condition out of samples arrived in the laboratory.

Timeliness of ES sample shipment

This was determined by the percentage of samples that arrive at a WHO-accredited lab < = 3 days of sample collection out of samples collected.

Thematic analysis was used to analyse the qualitative variables. All the audio recordings were transcribed while listening to the tapes and using the field notes taken. The transcripts were shared and read through thoroughly, independently, and repeatedly by three authors to ensure completeness and accuracy and also to obtain a sense of the data as a whole. Thematic analysis was carried out using usefulness and the system attributes as thematic areas. Initial codes were produced by one of the authors from list of ideas found to be interesting and relevant in the data which were later organized into meaningful groups. The generated codes were sorted out and merged to form potential themes. The initial themes were reviewed and refined into final themes taking into consideration internal homogeneity (ensuring everything in a theme is similar) and external heterogeneity (ensuring different contents in different themes). The themes were defined and named and detailed analysis conducted and written based on how they fit into the broader story of the data. Data was presented as text and graphs.

Ethical consideration

An introductory letter was obtained from the Regional Health Directorate that was used to obtain permission from the study districts to commence the data collection process. Verbal informed consent was also obtained from the study participants before the commencement of interviews. We interviewed each participant privately and maintained the confidentiality of the data obtained. The names of participants were not mentioned anywhere in the report. The data collected was password protected. This evaluation and interviews were done as part of a routine assessment by the Ghana Health Service and Ghana Field Epidemiology and Laboratory Training Program (GFELTP) under the Ghana Public Health Act 851 [15]. Identifiable data during data collection and analysis was not accessible by the authors.

Results

Overall, 48 sewage/wastewater samples were collected from 22nd January, 2019 to 22nd December, 2020. The mean temperature recorded for the samples collected was 23.9°C with a standard deviation of 3.3. The ES records indicate that out of the total 48 sewage/wastewater samples collected and sent for laboratory investigations; one 1(2.1%) yielded cVDPV2, 26(54.2%) had NPENT, 5(10.4%) had NPENT+Sabin and 1(2,1%) had Sabin 2 (Fig 3). The detection of this positive environmental isolate for cVDPV2 in June 2019, triggered an enhanced AFP surveillance in the region that also resulted in the detection of one positive AFP case of the same virus strain (cVDPV2) in August 2019 (Fig 4) in the Ando-Nyamanu community of Chereponi district, Northern region.

Fig 3. Sewage/Waste water samples collected and viruses detected, Northern Region, 2019–2020.

Fig 3

Fig 4. AFP cases by month, Northern Region, 2019–2020.

Fig 4

The ES surveillance performance indicators were also assessed. The findings show that all the indicators analyzed, performed above the world health Organization’s indicator performance target levels (Table 1).

Table 1. ES surveillance performance, Northern Region, Ghana, 2019–2020.

Indicator Target Regional Performance
Enterovirus detection > = 50% 66.7%
Completeness of sample collection > = 80% 100%
Timeliness of sample collection > = 80% 100%
Condition of ES sample > = 80% 100%
Timeliness of ES sample shipment > = 80% 100%

Attributes

Simplicity

The system’s operation flow chart (Fig 2) shows that data is shared among three organizations; the GHS, NMIMR, and the World Health Organization with only two reporting sites and few surveillance officers operating it. The surveillance officers do not need any structured training, but an orientation to carry out their duties. All the 6 (100%) respondents knew the purpose of the surveillance system. Sample collection is routine and does not demand rigorous identification of cases. A one-page reporting form that contains few variables is easily filled by data collectors. Within the two years period that this evaluation was conducted, all monthly samples were collected, all forms filled and dispatched on the same day of sample collection to NMIMR, laboratory investigations were done on all the samples submitted and feedback was given to the required authorities. For data analysis, simple descriptive statistics are performed.

Some views from respondents:

This is not different from the surveillance work we have been doing and as such we do not need any formal training on the environmental surveillance”

The environmental surveillance system help to know if there are polio viruses in the human population but are not noticed through the AFP surveillance”

The system is very simple, it is just once every month that we go for data collection and the forms we use are very simple and easy to fill………. Since we started, every time we collect the samples, we send them to Accra on the same day”

Flexibility

Data collected shows that, the system is integrated into the integrated disease surveillance and response (IDSR) system already in existence in Ghana. The ES system is also implemented through the same IDSR structures, surveillance officers, and reporting systems. Since already existing surveillance officers are operating the system, there was no need for any extensive training for the surveillance officers operating the system. Additionally, the system collects data on a few variables that are managed manually. One respondent said this:

The environmental surveillance is not a stand-alone system, it is part of the general surveillance system. We are the same officers involved so there is no rigidity in its operation”

Data quality

In all, 48 forms were filled within the period for the evaluation. Out of this, 97.9% (47/48) had all the required cells completely filled and very clear to read. The data captured on the forms filed at both the district and regional levels were consistent in content and readability. With regards to data validation, data collection forms are normally inspected at the time of receiving to be sure of their completeness.

Acceptability

Responses generated from the interviews showed that, all (100%) the officers interviewed carried out their assigned duties without any failure and were also willing to continue with the operation of the surveillance system despite their busy schedules. Data collectors at the surveillance sites were also willing to collect samples and fill out data collection forms every month. This was evidenced by the records reviewed which showed a 100% sample collection rate and a 97.9% form completion rate. Also, all (100%) samples were collected in the early mornings between 6:00 am and 10:00 am with the right sample collection containers and the standard ES data collection forms. All (100%) samples collected were dispatched to the NMIMR on the same day of collection. However, despite their willingness to continue with the ES activities, the data collectors suggested that more data collectors should be added to support the only two data collectors involved in ES activities.

Some views from respondents:

“…., just as I said, this is part of our work and we do not need additional pay to do it”

If for two years now, we have been able to collect all the monthly samples, it means that we are more than ready to continue with the samples collection”

“The only challenge we have is the few data collectors. We wish the number should be more so if one is not there, others will stand in for the work

Representativeness

Sewage/wastewater from every section in the surveillance area is drained all year-round into the large open drainage channels within which the samples are collected. Also, through records review, it was found that, throughout the two years, samples were collected every month from the two surveillance sites and sample adequacy was consistent. A participant has this to say:

“…, I have never seen this gutter dried up before, even in the dry season”

Timeliness

All (100%) samples were collected within the stipulated time of 4 weeks interval. It was observed that sample collection, form filling, and packaging take less than 60 minutes to complete. Samples collected were transported immediately to the Regional Surveillance office and subsequently dispatched to the national reference laboratory on the same day. It was also revealed that all (100%) samples received at the reference laboratory were processed and feedback was sent within two weeks to the national surveillance unit of the GHS as recommended.

Stability

There are dedicated surveillance officers at all levels (data collection sites, district level, regional level, and the national level) who are employed staff of the GHS. These officers are Government paid salary workers who indicated their willingness to work even in the absence of any extra pay. Because these staff members are already involved in AFP surveillance, they have the expected expertise to manage the operations of the ES. The system was fully operated throughout the two years without interruption from any source (personnel, electricity, or funding). Additionally, the drainage systems have good yields throughout the year. However, the system is not funded through the normal surveillance funding system. These were some views from some respondents:

“Any time we go there, we get waste water to collect

“Sample collection is not a problem at all, there is always enough waste water to fetch at any collection time

“We are using our own internally generated funds (IGF) to support the system. The NMIMR provides all the logistics support, laboratory reagents, consumables, and funding for the operation of the ES through our IGF

Sensitivity

Out of the 48 samples collected, 33 yielded viruses (cVDPV2, NPENT, Sabin and NPENT+Sabin), indicating the system’s sensitivity as 33/48 (68.8%).

Predictive value positive

Out of the 33 samples that yielded viruses (cVDPV2, NPENT, Sabin and NPENT+Sabin), only one (1) tested positive for cVDPV2, indicating the system’s predictive value positive as 1/33 (3.0%).

Usefulness

The system’s data has been used to cause public health actions. It was revealed that, after the positive environmental isolate of cVDPV2 in June 2019, there was an enhancement of AFP surveillance. Surveillance Officers in the region were quickly alerted to heighten active surveillance for AFP cases and pay strict attention to completeness and timeliness of reporting. Additionally, the surveillance Officers interviewed and the records reviewed indicated that the enhancement of the AFP surveillance activities, led to the detection of the AFP case in August 2019 in the region because of which polio vaccination exercises were organized in the region.

“After the detection of the cVDPV2 from the samples we sent, we were all alerted to enhance our AFP surveillance activities. We increase our supervision and also alerted our community health volunteers to be on the watch.., we belief this resulted in the detection of the AFP case a month later in the region

Discussion

The ES provides a system for routine surveillance of Poliovirus circulation independent of clinical disease. A study in Pakistan showed that, the ES is faster in detecting polio outbreaks than the AFP surveillance system [16]. This study also found that, the first cVDPV2 polio outbreak in the study area with preceding circulation detected by both ES and AFP surveillance, the ES detected the circulation sooner. The ES detected the cVDPV2 virus circulation more than two months before detection by AFP surveillance. This is similar to the Pakistan study where the ES was found to be most effective in detecting the circulation of Poliovirus from provinces conducting ES, with detecting about three months sooner than the AFP surveillance [16]. In the same study, it was revealed that transmission during low season and reintroductions were detected by the ES in the absence of clinical cases [16].

This evaluation also found that the ES findings were very useful in Ghana to guide programmatic public health responses to Polioviruses. The advantage offered by the ES in the Northern Region was used to characterize Poliovirus transmission and to appropriately focus response efforts such as supplemental immunization campaigns. For example, after the ES isolation of cVDPV2 in Koblimahgu surveillance sites in the Tamale Metropolis and the subsequence detection of a polio case in the Cheriponi District, public health officials rolled out three rounds of successful vaccination campaigns. Using findings from ES to implement control activities has also been demonstrated in several studies such as a study conducted in Pakistan, when eight OPV immunization campaigns among children aged <5 years were used to interrupt WPV transmission as a result of Poliovirus reported from the ES [16]. The response interventions in the Northern Region contributed to the interruption of cVDPV2 transmission in the area. Furthermore, the positive isolate from the environmental sample also triggered the conduct of a retroactive case search in the catchment area. During this house-to-house active case search, community members were sensitized on reporting AFP cases. This finding is also consistent with a study conducted in Nigeria to determine the contribution of ES toward the Interruption of Poliovirus Transmission [17]. This describes another dimension of public health intervention triggered by ES findings that helped to strengthen the AFP reporting system.

A public health surveillance system evaluation should emphasize those attributes that are most important for the objectives of the system [14]. The study assessed the attributes of a surveillance system and found that the ES in the Northern Region met most of the attributes of a good surveillance system. The system was found to be simple because data collection is routinely done with only one reporting form which contains few variables and as such easily filled by data collectors without any rigorous procedure. Additionally, only two reporting sites with few Surveillance Officers and Organizations are involved, making data sharing in the system very simple. These findings are similar to the study conducted in Bikita District, Masvingo Province [18] where the AFP system evaluated was found to be simple because of its usage of simple data tools and few reporting systems. However, these study findings are in contrast to a study in Zimbabwe, where a good number of respondents found it difficult to fill out the case investigation forms [19].

The Surveillance Officers attested to the ease of operation of the system, which is well structured, flexible to changes, and stable in its operations. The flexibility of the system has allowed the system to be integrated into the integrated disease surveillance and response system by using the same structures, surveillance officers, and reporting systems. The system has fully operated within the period of evaluation because of continuous drainage flow and dedicated surveillance officers with the requisite expertise to manage the system. Dedicated surveillance officers with requisite expertise as a measure of a stable surveillance system were also demonstrated in a study conducted in Bikita District, Masvingo Province [18]. One factor that threatens stability however is the source of funding. The NMIMR is the major funder, which provides logistics support for the transportation of samples to the reference laboratory, and the provision of some laboratory reagents and consumables. The NMIMR funds the ES from its IGF which may not be sustainable in times of insufficient IGF flow. In a similar study in Nigeria, it was also found that the majority of funding for the ES was also from partner agencies [20].

It is important to monitor data quality and thus ensure that the collected data are meaningful, so they meet the objectives of local, national, and international surveillance systems. The quality of the initial data may determine the data quality at all stages of the reporting process. Monitoring data quality also helps to improve data analysis and interpretation in public health reports at all levels. In terms of data quality, the completeness, readability, and timeliness of reporting were generally very good throughout the review period. With the exception of one form each, all the 48 forms filled within the two years period were completely filled and clear for reading. Meeting timelines with respect to data collection and transportation was 100%. Similar findings of high-quality surveillance system were seen in Oyo state [20] but contrary to findings in other similar studies, wherein some cases, the reporting was not complete and not timely [19] due to bad roads and lack of dedicated staff to transport samples to the laboratory on time. Even though data transmission to the national level was timely, we could not assess feedback due to lack of data. This can affect the future acceptability and quality of the ES operations if not immediately addressed.

The study found that the ES was generally acceptable to the surveillance officers. All the respondents were willing to continue with the ES. There was 100% execution of scheduled sample collection, transportation, and laboratory investigations by the Surveillance Officers. This finding is in line with several similar studies [18, 20]. This is probably because of the simplicity and ease of operation of the system and also, the intensification of support by the NMIMR and the GHS and personal commitment by officers towards the eradication of polio. However, despite their willingness to continue with the current system, the sample collectors suggested that more sample collectors should be orientated to support sample collection at the surveillance sites. The system was also represented. This was because Sewage/wastewater from every section in the surveillance area is drained all year-round into the large open drainage channels within which the samples were collected. Sample adequacy also met the WHO standard and was collected every month. The system was also found to be sensitive in detecting viruses but the predictive value positive was low. This is similar to a study finding in the Oyo state [20].

Limitations of the study

An area of deficiency observed was that, the data obtained lack information that could be used to quantify the timeliness of feedback. Additionally, the evaluation was limited by its size as more staff at all levels (District, Region National) could have also provided useful information, but the depth of the interviews yielded clear issues that are useful for the ES and GHS at large.

Conclusion

The ES system in the Northern region of Ghana met its objective of detecting circulating Poliovirus that aided the detection of a polio case. The ES is useful in generating data for making important public health decisions including the implementation of disease control activities such as mass polio vaccination campaigns. Regarding the attributes, data quality was good, the system was simple, flexible, acceptable, representative and fairly stable. Timeliness in reporting was good but feedback from the national level was poor.

Supporting information

S1 File. Suspected and confirmed cases.

(XLSX)

pone.0294305.s001.xlsx (10.7KB, xlsx)
S2 File. Characteristics of samples collected.

(XLSX)

pone.0294305.s002.xlsx (10.4KB, xlsx)
S3 File. Questionnaire.

(DOCX)

pone.0294305.s003.docx (19.8KB, docx)
S4 File. Sewage samples collected.

(XLSX)

pone.0294305.s004.xlsx (11.4KB, xlsx)

Acknowledgments

The authors would like to acknowledge with sincere gratitude, the sample collectors and other surveillance staff interviewed at the Districts, Regional, and National Surveillance Departments for their support and cooperation in the data collection process. We also acknowledge the staff of the Ghana Field Epidemiology and Laboratory Training Programme for their guidance and direction throughout the course of the evaluation.

Data Availability

Yes, all data are fully available without restriction.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.World Health Assembly. Global eradication of poliomyelitis by the year 2000. Geneva, Switzerland: WHA resolution no. WHA41.28, 1988.
  • 2.World Health Organization. Global detection of wild and vaccine-derived Polioviruses, January 2008–June 2009. Weekly Epidemiological Records 2009; 36: 366–371. 19764124 [Google Scholar]
  • 3.World Health Organization. Review of acute flaccid paralysis (AFP) surveillance in Iraq. Geneva, Switzerland: WHO, 2004. [Google Scholar]
  • 4.Centers for Disease Control and Prevention: tracking progress towards global polio eradication-worldwide, 2009–2010. MMWR Morb Mortal wkly Rep 2011, 60:441–445 [PubMed] [Google Scholar]
  • 5.Diop OM, Asghar H, Gavrilin E, Moeletsi NG, Benito GR, Paladin F, et al. Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016—Worldwide, 2016–2017. MMWR Morb Mortal Wkly Rep. 2017;66:538–42. doi: 10.15585/mmwr.mm6620a4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Odoom et al.: Evaluation of AFP surveillance indicators in polio-free Ghana, 2009–2013, BMC public Health 2014, 14:687. doi: 10.1186/1471-2458-14-687 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.GPEI: weekly updates on vaccine-Derived Poliovirus. https://polioeradication.org/polio-today/polio-now/this-week/, Assessed on 31st March, 2021. [Google Scholar]
  • 8.Kelly H, Brussen KA, Lawrence A, Elliot E, Pearn J, Thorley B. Polioviruses and other enteroviruses isolated from faecal samples of patients with acute flaccid paralysis in Australia, 1996–2004. J Paediatr Child Health. 2006. Jun;42(6):370–6. doi: 10.1111/j.1440-1754.2006.00875.x [DOI] [PubMed] [Google Scholar]
  • 9.Bassioni L, Barakat I, Nasr E, et al. Prolonged detection of indigenous wild Polioviruses in sewage from communities in Egypt. Am J Epidemiol 2003; 158:807–15. doi: 10.1093/aje/kwg202 [DOI] [PubMed] [Google Scholar]
  • 10.Odoom JK, Obodai E, Diamenu S, Ahove V, Addo J, et al. (2017) Environmental Surveillance for Poliovirus in Greater Accra and Eastern Regions of Ghana-2016. Virol Curr Res 1: 101. [Google Scholar]
  • 11.World Health Organization: Guidelines for environmental surveillance of Poliovirus circulation. World Health Organization, Department of Vaccines and Biologicals, 2003. (http://www.who.int/vaccines-documents/DoxGen/H5-Surv. htm). Accessed 6 October 2010. [Google Scholar]
  • 12.Weldegebriel G, Adeneji A, Gasasira A1, Okello D, Elemuwa C, et al. (2015) Environmental Surveillance for Poliovirus in Polio High Risk States of Nigeria, 2011–2012. Sci J Pub Hlth 3: 655–663. [Google Scholar]
  • 13.Muluh TJ, Hamisu AW, Craig K, Mkanda P, Andrew E, et al. (2016) Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012–2015. J Infect Dis 213: S131S135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Updated Guidelines for Evaluating Public Health Surveillance Systems Recommendations from the Guidelines Working Group, U.S. Department Of Health And Human Services Centers for Disease Control and Prevention (CDC) Atlanta, GA 303333. Westmoreland, D., Armstrong, G., Birkhead, G.S., & Epidemiologists, T. (2001).
  • 15.Ministry of Health. Public health act 851. Health Sector Acts. 2012 [cited 2022 Nov 1]. Available from: https://www.moh.gov.gh/health-sector-acts/
  • 16.Alam MM, Shaukat S, Sharif S, Angez M, Khurshid A, Malik F, et al. Detection of multiple cocirculating wild Poliovirus type 1 lineages through environmental surveillance: impact and progress during 2011–2013 in Pakistan. The Journal of infectious diseases. 2014; 210 Suppl 1:S324–32. Epub 2014/10/16. doi: 10.1093/infdis/jiu160 . [DOI] [PubMed] [Google Scholar]
  • 17.Mulih TJ., Hamisu AW., Craig K., Mkanda C., et al. Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012–2015. The Journal of infectious diseases. URL. doi: 10.1093/infdis/jiv767 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pomerai KW, Mfuta M Robert T, Muchekeza M Evaluation of the Acute Flacid Paralysis (AFP) Surveillance System in Bikita District Masvingo Province 2010. BMC Res Notes. 2014;7(252). doi: 10.1186/1756-0500-7-252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Muzondo M, Shamu A, Shambira G, Gombe NT, Juru TP, Tshimanga M. Evaluation of the acute flaccid paralysis (AFP) surveillance system in Mwenezi district, Masvingo, 2018: A descriptive study. BMC Res Notes. 2018. doi: 10.1186/s13104-018-3981-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Anyanwu M. Acute Flaccid Paralysis Surveillance system Evaluation, Oyo state, Nigeria; 2008–2014. Online J Public Health Inform. 2017. [Google Scholar]

Decision Letter 0

Enoch Aninagyei

20 Apr 2023

PONE-D-22-27652Evaluation of the Environmental Polio Surveillance System - Northern Region, Ghana, 2021PLOS ONE

Dear Mr Joseph Asamoah Frimpong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 04 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Enoch Aninagyei, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that Figure 1 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. 

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please include a separate caption for each figure in your manuscript.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is well written though a few typo and grammatical errors have bee indicated in the attached document. Other technical issues have also bee raised in the document that will require the authors to address them.

Good job

Reviewer #2: Evaluation of the Environmental Polio Surveillance 1 System - Northern Region, Ghana, 2021

At a point in time, there was an estimated 75,000 paralysed children in Africa due to Polio. The disease remains a devastating one in children from low-income countries. The Global Polio Eradication Initiative came into being to assist affected countries devise strategies to curb the spread through continuous vaccination and strict surveillance. The use of environmental specimen to assist surveillance appears to be ahead of waiting to see symptoms in affected persons. This is the relevance of this paper.

Apart from a few comments seen below, I think this was a great attempt to assess the usefulness of environmental surveillance towards polio eradication.

55-56. Maybe add reasons for the global decrease in polio reports since 1988.

62. Neighbouring countries from the southern or northern part. I want to assume these outbreaks came from northern part of Ghana?

94. Northern region

335. What parameter are you using to determine delays. Is there a stipulated time that could be used to measure this? It would have been good if data is shown on national level delays a bit.

335-336. Is the quarterly submission of results from national or Nogushi the norm? Did you find out?

348. All year round

Reviewer #3: Summary

This is an important paper describing the environmental surveillance system in northern Ghana for poliovirus. The authors describe its justification and the role it plays to complement the gold standard acute flaccid paralysis case surveillance, alongside the quality and timeliness of the data

Major comments

The introduction has some inaccuracies that need to be corrected before publication. I have listed them below.

It would be very helpful to the reader to include a map of the Northern region showing the location of the two ES sites and the corresponding drainage settlements, and the location of the cVDPV2 AFP case.

It is not clear if the ES sites pass the WHO’s ES performance criteria (Table 5 of http://polioeradication.org/wp-content/uploads/2022/11/Field-Guidance-for-the-Implementation-of-ES-20221118-ENG.pdf) This is essential. It is important to document the detection of enterovirus and Sabin strains from ES sites but this is currently absent from the paper. The sites should be assessed whether they meet the WHO criteria.

Minor comments

Abstract: please include the precise dates of the study period

Abstract: The version of Excel seems excessive for the abstract

Abstract: ‘Feedbacks were not regular’ – can you quantify this statement. What proportion of results took longer than a month or another appropriate timeframe? Feedback to who?

Introduction:

Line56: 1988 – it would be clearer if you explained this is when the Eradication Initiative began.

Line 57 No wild type 3 Poliovirus since October 1999 in incorrect. Please correct this

Line 60: The last case of wild polio in Nigeria was in 2016 not 2014

Line 64: Please define what vaccine derived poliovirus is

Lines 81-82: Unfortunately seems the wrong choice of word. Also poliovirus isn’t in circulation in the environment (it’s detection can indicate circulation but it does not replicate in the environment).

Line 94: Northern region. Where else in the country is ES implemented? Why is the Northern region important? Because of historic WPV circulation?

Methods

Line 116 – how were the site locations selected?

Line 117 – what methods were used to assess the location of the drainage settlements? Was the sewage network mapped?

Line 131 – It would be helpful to include the questionnaire in the appendix

Line 156: What do you mean by ‘results are sent to the region’. Who in the region? Are they also sent to national representatives at the same time?

Line 168: ‘Stool turns positive’ I think you mean tests positive. A stool doesn’t turn positive

Results:

Line 227 – what are the other priority diseases?

Line 255 – delayed by how long?

Figure 3: Positive for what – cVDPV2? It would be interesting to show the number positive for Sabin 1,2,3 and non-polio enterovirus as well

Figure 4 – Suspected – do you mean non-polio AFP? Confirmed, confirmed for what? cVDPV2? It would be helpful to show the timings of the vaccination campaigns.

Discussion:

Line 277 – ES is faster – do you mean in this setting or more generally? If the latter please provide a reference.

Line 279 – On average, this is an average over what?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Manuscript.docx

pone.0294305.s005.docx (67.9KB, docx)
PLoS One. 2024 Feb 29;19(2):e0294305. doi: 10.1371/journal.pone.0294305.r002

Author response to Decision Letter 0


5 Jun 2023

A rebuttal letter that responds to each point raised by the academic editor and reviewer has been uploaded.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0294305.s006.docx (19.9KB, docx)

Decision Letter 1

Enoch Aninagyei

28 Jun 2023

PONE-D-22-27652R1Evaluation of the Environmental Polio Surveillance System - Northern Region, Ghana, 2021PLOS ONE

Dear Dr. Asamoah Frimpong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 12 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Enoch Aninagyei, PhD

Academic Editor

PLOS ONE

Additional Editor Comments:

The Reviewer of the revised version actually rejected the manuscript, citing the following reasons. However, I want to give you the opportunity to address them for consideration.

This publication is a descriptive summary of findings linked to an evaluation of poliovirus wastewater surveillance in Northern Ghana from 2019 to 2020. Below are the rationale for the recommendation to reject this publication:

1)The authors state that they follow the CDC guidelines for evaluating a surveillance system but they have excluded some critical assessments such as sensitivity and predictive value positive.

2) The population of the area under surveillance is 2.3million yet the sampling is done for a population of about 70,000 people, short of the 100,000 to 300,000 recommended for global polio surveillance. It is unclear how this sampling location was selected. Is this sample size sufficient for ongoing surveillance and monitoring?

3) For the subjective aspects of the evaluation, little data was shared regarding staff surveys/interviews regarding their feedback e.g. no summary of responses to specific questions though a data collection tool was mentioned.

4) Other factors to consider in evaluating wastewater surveillance particularly where there is a low risk of wild poliovirus or vdpv include the detection of Sabin strains from OPV use (i.e. correlation with immunization days) and non-polio enteroviruses (NPEV) used as proxy indicators to regularly monitor, validate, and compare site sensitivity. These indicators were not assessed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: No

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: This publication is a descriptive summary of findings linked to an evaluation of poliovirus wastewater surveillance in Northern Ghana from 2019 to 2020. Below are the rationale for the recommendation to reject this publication:

1)The authors state that they follow the CDC guidelines for evaluating a surveillance system but they have excluded some critical assessments such as sensitivity and predictive value positive.

2) The population of the area under surveillance is 2.3million yet the sampling is done for a population of about 70,000 people, short of the 100,000 to 300,000 recommended for global polio surveillance. It is unclear how this sampling location was selected. Is this sample size sufficient for ongoing surveillance and monitoring?

3) For the subjective aspects of the evaluation, little data was shared regarding staff surveys/interviews regarding their feedback e.g. no summary of responses to specific questions though a data collection tool was mentioned.

4) Other factors to consider in evaluating wastewater surveillance particularly where there is a low risk of wild poliovirus or vdpv include the detection of Sabin strains from OPV use (i.e. correlation with immunization days) and non-polio enteroviruses (NPEV) used as proxy indicators to regularly monitor, validate, and compare site sensitivity. These indicators were not assessed.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Feb 29;19(2):e0294305. doi: 10.1371/journal.pone.0294305.r004

Author response to Decision Letter 1


23 Aug 2023

Comment 1:The authors state that they follow the CDC guidelines for evaluating a surveillance system but they have excluded some critical assessments such as sensitivity and predictive value positive.

Response: We are grateful for the comment. We have revised the manuscript to provide information on sensitivity and predictive value positive

Details: Page 2, lines 44-45

Page 8, lines 174-178

Page 14, lines 332-336

Page 18, lines 422-423

Comment 2: The population of the area under surveillance is 2.3million yet the sampling is done for a population of about 70,000 people, short of the 100,000 to 300,000 recommended for global polio surveillance. It is unclear how this sampling location was selected. Is this sample size sufficient for ongoing surveillance and monitoring?

Response: We are grateful for the comment. We initially only considered communities around the sample collection sites. However, other communities at the upper part of the sample collection sites feed into the drain and sewer lines but were not classified as drainage settlement. These communities have been added making the total population to be 102,653 (70,310 for Nyanshegu and 32,343 for Koblimahgu).

Details: Page 6, lines 128-133

In addition to the population (102,653), the sampling location was selected based on four criteria

Details: Page 6, lines 122-126

Comment 3: For the subjective aspects of the evaluation, little data was shared regarding staff surveys/interviews regarding their feedback e.g. no summary of responses to specific questions though a data collection tool was mentioned.

Response: We are grateful for the comment. We have revised the manuscript to include some direct quotations from respondents

Details: Page 12 - 15, lines 270-349

Comment 4: Other factors to consider in evaluating wastewater surveillance particularly where there is a low risk of wild poliovirus or vdpv include the detection of Sabin strains from OPV use (i.e. correlation with immunisation days) and non-polio enteroviruses (NPEV) used as proxy indicators to regularly monitor, validate, and compare site sensitivity. These indicators were not assessed.

Response: We are grateful for the comment.

The manuscript has been revised to include results on NPENT, Sabin and NPENT+Sabin viruses detected and were used in calculating the sensitivity.

Details:

Page 14, lines 332-336

Page 10 - 11, lines 244 - 246

Figure 3 has been updated to reflect this

Attachment

Submitted filename: Response to Reviewers.docx

pone.0294305.s007.docx (19.6KB, docx)

Decision Letter 2

Enoch Aninagyei

6 Sep 2023

PONE-D-22-27652R2Evaluation of the Environmental Polio Surveillance System - Northern Region, Ghana, 2021PLOS ONE

Dear Dr. Frimpong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:One of the reviewers made these comments. However, I did not see these revisions. Kindly respond to them for consideration. This publication is a descriptive summary of findings linked to an evaluation of poliovirus wastewater surveillance in Northern Ghana from 2019 to 2020. Below are the rationale for the recommendation to reject this publication:

1)The authors state that they follow the CDC guidelines for evaluating a surveillance system but they have excluded some critical assessments such as sensitivity and predictive value positive.

2) The population of the area under surveillance is 2.3million yet the sampling is done for a population of about 70,000 people, short of the 100,000 to 300,000 recommended for global polio surveillance. It is unclear how this sampling location was selected. Is this sample size sufficient for ongoing surveillance and monitoring?

3) For the subjective aspects of the evaluation, little data was shared regarding staff surveys/interviews regarding their feedback e.g. no summary of responses to specific questions though a data collection tool was mentioned.

4) Other factors to consider in evaluating wastewater surveillance particularly where there is a low risk of wild poliovirus or vdpv include the detection of Sabin strains from OPV use (i.e. correlation with immunization days) and non-polio enteroviruses (NPEV) used as proxy indicators to regularly monitor, validate, and compare site sensitivity. These indicators were not assessed.

==============================

Please submit your revised manuscript by Oct 21 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Enoch Aninagyei, PhD

Academic Editor

PLOS ONE

Additional Editor Comments:

This publication is a descriptive summary of findings linked to an evaluation of poliovirus wastewater surveillance in Northern Ghana from 2019 to 2020. Below are the rationale for the recommendation to reject this publication:

1)The authors state that they follow the CDC guidelines for evaluating a surveillance system but they have excluded some critical assessments such as sensitivity and predictive value positive.

2) The population of the area under surveillance is 2.3million yet the sampling is done for a population of about 70,000 people, short of the 100,000 to 300,000 recommended for global polio surveillance. It is unclear how this sampling location was selected. Is this sample size sufficient for ongoing surveillance and monitoring?

3) For the subjective aspects of the evaluation, little data was shared regarding staff surveys/interviews regarding their feedback e.g. no summary of responses to specific questions though a data collection tool was mentioned.

4) Other factors to consider in evaluating wastewater surveillance particularly where there is a low risk of wild poliovirus or vdpv include the detection of Sabin strains from OPV use (i.e. correlation with immunization days) and non-polio enteroviruses (NPEV) used as proxy indicators to regularly monitor, validate, and compare site sensitivity. These indicators were not assessed.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Feb 29;19(2):e0294305. doi: 10.1371/journal.pone.0294305.r006

Author response to Decision Letter 2


5 Oct 2023

1) The authors state that they follow the CDC guidelines for evaluating a surveillance system but they have excluded some critical assessments such as sensitivity and predictive value positive.

Response:

We are grateful for the comment. We have revised the manuscript to provide information on sensitivity and predictive value positive

Details: Page 2, lines 44-45

Page 8, lines 174-178

Page 14, lines 332-336

Page 18, lines 422-423

2) The population of the area under surveillance is 2.3million yet the sampling is done for a population of about 70,000 people, short of the 100,000 to 300,000 recommended for global polio surveillance. It is unclear how this sampling location was selected. Is this sample size sufficient for ongoing surveillance and monitoring?

Response:

We are grateful for the comment. We initially only considered communities around the sample collection sites. However, other communities at the upper part of the sample collection sites feed into the drain and sewer lines but were not classified as drainage settlement. These communities have been added making the total population to be 102,653 (70,310 for Nyanshegu and 32,343 for Koblimahgu).

Details: Page 6, lines 128-133

In addition to the population (102,653), the sampling location was selected based on four criteria

Details: Page 6, lines 122-126

3) For the subjective aspects of the evaluation, little data was shared regarding staff surveys/interviews regarding their feedback e.g. no summary of responses to specific questions though a data collection tool was mentioned.

Response:

We are grateful for the comment. We have revised the manuscript to include some direct quotations from respondents

Details: Page 12 - 15, lines 270-349

4) Other factors to consider in evaluating wastewater surveillance particularly where there is a low risk of wild poliovirus or vdpv include the detection of Sabin strains from OPV use (i.e. correlation with immunization days) and non-polio enteroviruses (NPEV) used as proxy indicators to regularly monitor, validate, and compare site sensitivity. These indicators were not assessed

Response:

We are grateful for the comment.

The manuscript has been revised to include results on NPENT, Sabin and NPENT+Sabin viruses detected and were used in calculating the sensivity.

Details:

Page 14, lines 332-336

Page 10 - 11, lines 244 - 246

Refer to Figure 3

Attachment

Submitted filename: Response to Reviewers.docx

pone.0294305.s008.docx (19.6KB, docx)

Decision Letter 3

Enoch Aninagyei

31 Oct 2023

Evaluation of the Environmental Polio Surveillance System - Northern Region, Ghana, 2021

PONE-D-22-27652R3

Dear Dr. Asamoah Frimpong,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Enoch Aninagyei, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Enoch Aninagyei

13 Nov 2023

PONE-D-22-27652R3

Evaluation of the Environmental Polio Surveillance System - Northern Region, Ghana, 2021

Dear Dr. Frimpong:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Enoch Aninagyei

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Suspected and confirmed cases.

    (XLSX)

    pone.0294305.s001.xlsx (10.7KB, xlsx)
    S2 File. Characteristics of samples collected.

    (XLSX)

    pone.0294305.s002.xlsx (10.4KB, xlsx)
    S3 File. Questionnaire.

    (DOCX)

    pone.0294305.s003.docx (19.8KB, docx)
    S4 File. Sewage samples collected.

    (XLSX)

    pone.0294305.s004.xlsx (11.4KB, xlsx)
    Attachment

    Submitted filename: Manuscript.docx

    pone.0294305.s005.docx (67.9KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0294305.s006.docx (19.9KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0294305.s007.docx (19.6KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0294305.s008.docx (19.6KB, docx)

    Data Availability Statement

    Yes, all data are fully available without restriction.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES